July 2026 - Australian healthcare company invests $1.39 million for 10.2% of molecular diagnostics firm to expand market reach and product synergy.

July 2026 - ASX-listed BCAL Diagnostics invests $1.39 million for 10.2% of molecular diagnostics firm, aiming to expand market reach and leverage complementary capabilities.

Arizona is boosting its defenses against the New World screwworm as the deadly parasite threatens U.S. livestock again.

We spoke to David Klenerman, co-developer of sequencing by synthesis, to find out how his work heralded the next generation ...

Scientists say it has the potential to extend lives by helping doctors identify patients whose disease is more likely to ...

Stanford researchers have developed Microbe-Independent Deep Assembly and Screening – MIDAS – a polymerase chain ...

Countable Labs inks agreement with Promega to facilitate biological sample preparation and rare variant detection: Palo Alto, California Monday, June 29, 2026, 16:00 Hrs [IST] Cou ...

This article explores how advances in qPCR are improving speed, sensitivity, and portability, enabling faster diagnostics and ...

NCCN now recognizes personalized, tumor-informed ctDNA-MRD as a prognostic and predictive biomarker in MIBC, extending ...